Edition:
United States

Aquinox Pharmaceuticals Inc (AQXP.OQ)

AQXP.OQ on NASDAQ Stock Exchange Global Market

14.62USD
16 Feb 2018
Change (% chg)

$-1.69 (-10.36%)
Prev Close
$16.31
Open
$16.36
Day's High
$16.75
Day's Low
$14.47
Volume
47,543
Avg. Vol
30,960
52-wk High
$19.35
52-wk Low
$10.03

Chart for

About

Aquinox Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company discovering and developing targeted therapeutics in disease areas of inflammation and immuno-oncology. The Company's primary focus is anti-inflammatory product candidates targeting the Src Homology 2 (SH2)-containing inositol-5-phosphatase 1 (SHIP1) enzyme,... (more)

Overall

Beta: --
Market Cap(Mil.): $343.06
Shares Outstanding(Mil.): 23.46
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 32.03 17.27
EPS (TTM): -- -- --
ROI: -- 14.00 35.43
ROE: -- 15.34 17.10

BRIEF-Aquinox Provides Enrollment Update For Leadership 301 Clinical Trial Of Rosiptor

* AQUINOX PROVIDES ENROLLMENT UPDATE FOR LEADERSHIP 301 CLINICAL TRIAL OF ROSIPTOR

Feb 09 2018

BRIEF-‍Aquinox Statement On Fda Advisory Committee Meeting To Discuss Interstitial Cystitis/Bladder Pain Syndrome​

* ‍AQUINOX STATEMENT ON FDA ADVISORY COMMITTEE MEETING TO DISCUSS INTERSTITIAL CYSTITIS/BLADDER PAIN SYNDROME​

Dec 07 2017

BRIEF-Aquinox Pharmaceuticals qtrly ‍net loss per share $0.50​

* Aquinox Pharmaceuticals announces third quarter 2017 financial results

Nov 08 2017

Earnings vs. Estimates